-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
-
Summary
-
OnKure Therapeutics, Inc. annual and quarterly Net Cash Provided by (Used in) Financing Activities in USD history and change rate from 31 Mar 2020 to 31 Dec 2025.
- OnKure Therapeutics, Inc. Net Cash Provided by (Used in) Financing Activities for the quarter ending 31 Mar 2025 was $77,000, a 870% decline year-over-year.
- OnKure Therapeutics, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2025 was $163,000, a 100% decline from 2024.
- OnKure Therapeutics, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2024 was $116,129,000, a 119% increase from 2023.
- OnKure Therapeutics, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2023 was $53,125,000, a 11179% increase from 2022.